JINARC-PASS

Full title: A 9-year, Multicentre, Non-interventional, Post-authorisation Safety Study for Patients Prescribed JINARC® for Autosomal Dominant Polycystic Kidney Disease

Details: This PASS is a multicentre, prospective, observational study of patients being treated with JINARC for ADPKD to better characterise specified known risks in real world treatment through evaluation of AEs and prescribing habits, and collection of data from patients with limited information from clinical trials

Specialty: Renal Disease

Principal Investigator: Professor Donal Reddan

Study status: Follow up

Identifier: EUPAS12842